Fulranumab

fulranumab · Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Fulranumab, covering 2017-09-14 to 2025-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3003 [Phase 3]